What does DuKe Medical do?

DuKe Medical is a specialist medical practice in Sint-Pieters-Woluwe. Private Limited, started on 8 June 2012, 1 establishment.

What is the address of DuKe Medical?

The registered office of DuKe Medical is located at Hertogstraat 76, 1150 Sint-Pieters-Woluwe.

Is DuKe Medical still active?

Yes. According to the CBE (2 November 2026) DuKe Medical is active, legal situation “Normale toestand”, started on 8 June 2012.

Is DuKe Medical registered on Peppol?

Yes, DuKe Medical is registered on the Peppol network with ID 0208:0846458226.

What is the enterprise number of DuKe Medical?

The enterprise number of DuKe Medical is BE0846458226.

When was DuKe Medical founded?

DuKe Medical was founded on 8 June 2012.

Who are the directors of DuKe Medical?

According to the 2025 annual accounts, the directors of DuKe Medical are: Serge De Lathouwer, Barbara Kadz.

Is DuKe Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 June 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did DuKe Medical make in 2025?

DuKe Medical posted a profit after taxes of € 124,809 in financial year 2025.

What is the revenue of DuKe Medical?

As a small company, DuKe Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 341,098.

DuKe Medical (Private Limited) - Sint-Pieters-Woluwe

Dossier DuKe Medical, printed on 3 November 2026 from databakkes.be/en/0846458226/duke-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DuKe Medical from Sint-Pieters-Woluwe, company number BE0846458226, closed financial year 2025 with a result of € 124,809 after tax. For that financial year DuKe Medical recorded a gross margin of € 341,098 and equity of € 763,730. Compared with financial year 2024, the result moved from € 168,828 to € 124,809. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Growing

€ 763,730

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 124,809

▼ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 91,519

▼ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 78,946 paid out

63 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 9,387

▲ 14% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 26,698

▲ € 20,558 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 350,000

€ 32,759 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 18,833

▲ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 477

▼ 98% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 295,780 Gross margin 2022: € 295,780 First fiscal year in the series	€ 285,541 Gross margin 2023: € 285,541 ▼ 3% vs 2022 (€ 295,780) Unfavourable step	€ 284,601 Gross margin 2024: € 284,601 Unchanged (€ 285,541) Unfavourable step	€ 341,098 Gross margin 2025: € 341,098 ▲ 20% vs 2024 (€ 284,601) Favourable step	▲ 20%
Profit after taxes	€ 142,354 Profit after taxes 2022: € 142,354 First fiscal year in the series	€ 167,359 Profit after taxes 2023: € 167,359 ▲ 18% vs 2022 (€ 142,354) Favourable step	€ 168,828 Profit after taxes 2024: € 168,828 ▲ 1% vs 2023 (€ 167,359) Favourable step	€ 124,809 Profit after taxes 2025: € 124,809 ▼ 26% vs 2024 (€ 168,828) Unfavourable step	▼ 26%
Equity	€ 603,644 Equity 2022: € 603,644 First fiscal year in the series	€ 665,207 Equity 2023: € 665,207 ▲ 10% vs 2022 (€ 603,644) Favourable step	€ 717,867 Equity 2024: € 717,867 ▲ 8% vs 2023 (€ 665,207) Favourable step	€ 763,730 Equity 2025: € 763,730 ▲ 6% vs 2024 (€ 717,867) Favourable step	▲ 6%
Total debts	€ 104,332 Total debts 2022: € 104,332 First fiscal year in the series	€ 218,096 Total debts 2023: € 218,096 ▲ 109% vs 2022 (€ 104,332) Unfavourable step	€ 196,751 Total debts 2024: € 196,751 ▼ 10% vs 2023 (€ 218,096) Favourable step	€ 461,989 Total debts 2025: € 461,989 ▲ 135% vs 2024 (€ 196,751) Unfavourable step	▲ 135%
Cash	€ 384,617 Cash 2022: € 384,617 First fiscal year in the series	€ 581,841 Cash 2023: € 581,841 ▲ 51% vs 2022 (€ 384,617) Favourable step	€ 645,783 Cash 2024: € 645,783 ▲ 11% vs 2023 (€ 581,841) Favourable step	€ 91,519 Cash 2025: € 91,519 ▼ 86% vs 2024 (€ 645,783) Unfavourable step	▼ 86%
Land & buildings	€ 246,010 Land & buildings 2022: € 246,010 First fiscal year in the series	€ 228,327 Land & buildings 2023: € 228,327 ▼ 7% vs 2022 (€ 246,010) Unchanged	€ 210,644 Land & buildings 2024: € 210,644 ▼ 8% vs 2023 (€ 228,327) Unchanged	€ 1,039,370 Land & buildings 2025: € 1,039,370 ▲ € 828,726 vs 2024 (€ 210,644) Unchanged	▲ € 828,726
Retained profit	€ 603,644 Retained profit 2022: € 603,644 First fiscal year in the series	€ 665,207 Retained profit 2023: € 665,207 ▲ 10% vs 2022 (€ 603,644) Favourable step	€ 717,867 Retained profit 2024: € 717,867 ▲ 8% vs 2023 (€ 665,207) Favourable step	€ 763,730 Retained profit 2025: € 763,730 ▲ 6% vs 2024 (€ 717,867) Favourable step	▲ 6%
Dividend	€ 14,237 Dividend 2022: € 14,237 First fiscal year in the series	€ 105,796 Dividend 2023: € 105,796 ▲ € 91,560 vs 2022 (€ 14,237) Unchanged	€ 116,168 Dividend 2024: € 116,168 ▲ 10% vs 2023 (€ 105,796) Unchanged	€ 78,946 Dividend 2025: € 78,946 ▼ 32% vs 2024 (€ 116,168) Unchanged	▼ 32%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 350,000 Bank debt 2025: € 350,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 707,976 Balance sheet total 2022: € 707,976 First fiscal year in the series	€ 883,304 Balance sheet total 2023: € 883,304 ▲ 25% vs 2022 (€ 707,976) Unchanged	€ 914,618 Balance sheet total 2024: € 914,618 ▲ 4% vs 2023 (€ 883,304) Unchanged	€ 1,225,718 Balance sheet total 2025: € 1,225,718 ▲ 34% vs 2024 (€ 914,618) Unchanged	▲ 34%

Key figures of DuKe Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DuKe Medical?

What happened at DuKe Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 124,809 (▼ 26% vs 2024). Source: NBB ↗
Jun 12, 2012 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jun 8, 2012 New establishment in Sint-Pieters-Woluwe. KBO

In short

From € 142,354 profit in 2022 to € 124,809 profit in 2025.

Paid € 277,352 in corporate taxes since 2022.

Best year ever: 2024, with € 168,828 profit.

Paid out € 315,147 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Serge De Lathouwer Barbara Kadz

DuKe Medical

Behind DuKe Medical are Serge De Lathouwer and Barbara Kadz.

Directors

According to the 2025 annual accounts

Serge De Lathouwer

Director

Barbara Kadz

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hertogstraat 76

1150 Sint-Pieters-Woluwe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

12 June 2012 Source: Deed ↗

DE LATHOUWER Serge(oprichter) 50%
KADZ Barbara Simy(oprichter) 50%

Details

Company number: 0846.458.226
VAT number: BE 0846.458.226
Registered office: Hertogstraat 76, 1150 Sint-Pieters-Woluwe
Names & denominations: DuKe Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 June 2012
Peppol: Active · Active since 29 Oct 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗